These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16777453

  • 1. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.
    Nguyen AD, Pan CJ, Weinstein DA, Chou JY.
    Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453
    [Abstract] [Full Text] [Related]

  • 2. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S.
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [Abstract] [Full Text] [Related]

  • 3. Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis.
    Nguyen AD, Pan CJ, Shieh JJ, Chou JY.
    FEBS Lett; 2005 Aug 29; 579(21):4713-8. PubMed ID: 16098970
    [Abstract] [Full Text] [Related]

  • 4. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
    Svensson PA, Englund MC, Snäckestrand MS, Hägg DA, Ohlsson BG, Stemme V, Mattsson-Hulten L, Thelle DS, Fagerberg B, Wiklund O, Carlsson LM, Carlsson B.
    BMC Cardiovasc Disord; 2005 Aug 25; 5():25. PubMed ID: 16122381
    [Abstract] [Full Text] [Related]

  • 5. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S.
    J Trace Elem Med Biol; 2010 Jan 25; 24(1):42-5. PubMed ID: 20122579
    [Abstract] [Full Text] [Related]

  • 6. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 25; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 7. Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes.
    Shetty S, Eckhardt ER, Post SR, van der Westhuyzen DR.
    Arterioscler Thromb Vasc Biol; 2006 Sep 25; 26(9):2125-31. PubMed ID: 16794223
    [Abstract] [Full Text] [Related]

  • 8. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
    Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschütter A.
    Free Radic Biol Med; 2002 Jul 01; 33(1):103-10. PubMed ID: 12086688
    [Abstract] [Full Text] [Related]

  • 9. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux.
    Chroni A, Nieland TJ, Kypreos KE, Krieger M, Zannis VI.
    Biochemistry; 2005 Oct 04; 44(39):13132-43. PubMed ID: 16185081
    [Abstract] [Full Text] [Related]

  • 10. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H, Hirano K, Ohtake A, Miida T, Takatani T, Murayama K, Yorifuji T, Kobayashi K, Kanazawa M, Ogawa A, Takayanagi M.
    Eur J Pediatr; 2007 Oct 04; 166(10):1009-16. PubMed ID: 17206455
    [Abstract] [Full Text] [Related]

  • 11. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
    Harder C, Lau P, Meng A, Whitman SC, McPherson R.
    Arterioscler Thromb Vasc Biol; 2007 Apr 04; 27(4):858-64. PubMed ID: 17272756
    [Abstract] [Full Text] [Related]

  • 12. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression.
    Murao K, Yu X, Imachi H, Cao WM, Chen K, Matsumoto K, Nishiuchi T, Wong NC, Ishida T.
    Am J Physiol Endocrinol Metab; 2008 Jan 04; 294(1):E78-87. PubMed ID: 17957039
    [Abstract] [Full Text] [Related]

  • 13. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C, Watanabe T, Zhang Y, Trigatti B, Szeto L, Connelly PW, Marcovina S, Vaisar T, Heinecke JW, Lewis GF.
    Circ Res; 2008 Jul 18; 103(2):159-66. PubMed ID: 18556574
    [Abstract] [Full Text] [Related]

  • 14. Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat.
    Jeyakumar SM, Vajreswari A, Giridharan NV.
    Obesity (Silver Spring); 2007 Feb 18; 15(2):322-9. PubMed ID: 17299104
    [Abstract] [Full Text] [Related]

  • 15. Estrogen regulation of the scavenger receptor class B gene: Anti-atherogenic or steroidogenic, is there a priority?
    Lopez D, McLean MP.
    Mol Cell Endocrinol; 2006 Mar 09; 247(1-2):22-33. PubMed ID: 16297529
    [Abstract] [Full Text] [Related]

  • 16. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.
    Yekeler E, Dursun M, Emeksiz E, Akkoyunlu M, Akyol Y, Demir F, Gökcay G, Demirkol M.
    Turk J Pediatr; 2007 Mar 09; 49(2):115-9. PubMed ID: 17907509
    [Abstract] [Full Text] [Related]

  • 17. Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib.
    Bashan N, Hagai Y, Potashnik R, Moses SW.
    J Clin Invest; 1988 May 09; 81(5):1317-22. PubMed ID: 3163346
    [Abstract] [Full Text] [Related]

  • 18. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Nov 09; 26(11):2552-9. PubMed ID: 16946130
    [Abstract] [Full Text] [Related]

  • 19. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.
    Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, Rice HE, Clary BM.
    J Hepatol; 2007 Nov 09; 47(5):658-63. PubMed ID: 17637480
    [Abstract] [Full Text] [Related]

  • 20. Effects of niacin and Niaspan on HDL lipoprotein cellular SR-BI-mediated cholesterol efflux.
    Morgan JM, de la Llera-Moya M, Capuzzi DM.
    J Clin Lipidol; 2007 Dec 09; 1(6):614-9. PubMed ID: 21291703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.